Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Microlipid is an enteral fat supplement formulated as a concentrated emulsion of safflower oil. It is primarily used to increase the caloric density of feedings for patients with high energy requirements or fluid restrictions, such as very low birth weight (VLBW) infants in the neonatal intensive care unit (NICU) and individuals with short bowel syndrome or malabsorption disorders. By providing a concentrated source of long-chain polyunsaturated fatty acids (primarily linoleic acid, an omega-6 fatty acid), Microlipid helps optimize growth, improve protein absorption, and facilitate intestinal adaptation, often allowing for a reduction in the use of parenteral nutrition. It is commonly used for targeted breast milk fortification and in the management of infants with enterostomies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Microlipid.